Teladoc Health (TDOC) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

TDOC Stock Forecast

Teladoc Health stock forecast is as follows: an average price target of $50.87 (represents a 465.22% upside from TDOC’s last price of $9.00) and a rating consensus of 'Hold', based on 21 wall street analysts offering a 1-year stock forecast.

TDOC Price Target

The average price target for Teladoc Health (TDOC) is $50.87 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $150.00 to $9.00. This represents a potential 465.22% upside from TDOC's last price of $9.00.

TDOC Analyst Ratings

Hold

According to 21 Wall Street analysts, Teladoc Health's rating consensus is 'Hold'. The analyst rating breakdown for TDOC stock is 0 'Strong Buy' (0.00%), 10 'Buy' (47.62%), 11 'Hold' (52.38%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Teladoc Health Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 31, 2024	Daniel Grosslight	Citigroup	$11.00	$8.86	24.15%	22.22%
Oct 30, 2024	Elizabeth Anderson	Evercore ISI	$9.00	$8.86	1.58%	-
Aug 06, 2024	Jessica Tassan	Piper Sandler	$10.00	$7.60	31.58%	11.11%
Jun 11, 2024	Steve Valiquette	Barclays	$20.00	$10.48	90.75%	122.22%
May 31, 2024	Glen Santangelo	Jefferies	$10.00	$11.29	-11.43%	11.11%
May 20, 2024	Glen Santangelo	Jefferies	$14.00	$12.39	12.99%	55.56%
Apr 05, 2024	George Hill	Deutsche Bank	$18.00	$14.64	22.91%	100.00%
Apr 12, 2023	Jeff Garro	Stephens	$25.00	$25.86	-3.33%	177.78%
Dec 13, 2022	-	Citigroup	$33.00	$27.63	19.44%	266.67%
Sep 28, 2022	-	RBC Capital	$35.00	$27.52	27.18%	288.89%

Row per page

Go to

The latest Teladoc Health stock forecast, released on Oct 31, 2024 by Daniel Grosslight from Citigroup, set a price target of $11.00, which represents a 24.15% increase from the stock price at the time of the forecast ($8.86), and a 22.22% increase from TDOC last price ($9.00).

Teladoc Health Price Target by Period

	1M	3M	12M
# Anlaysts	2	2	7
Avg Price Target	$10.00	$10.00	$13.14
Last Closing Price	$9.00	$9.00	$9.00
Upside/Downside	11.11%	11.11%	46.00%

In the current month, the average price target of Teladoc Health stock is $10.00, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 11.11% increase as opposed to Teladoc Health's last price of $9.00. This month's average price target is down 0.00% compared to last quarter, and down -23.90% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 31, 2024	Cowen & Co.	Hold	Hold	Hold
Oct 31, 2024	Barclays	Overweight	Overweight	Hold
Oct 31, 2024	Citigroup	Neutral	Neutral	Hold
Oct 09, 2024	RBC Capital	Outperform	Outperform	Hold
Oct 08, 2024	RBC Capital	Buy	Buy	Hold
Oct 08, 2024	Evercore ISI	Outperform	Outperform	Hold
Sep 17, 2024	Piper Sandler	Underperform	Underperform	Hold
Sep 17, 2024	RBC Capital	Buy	Buy	Hold
Sep 17, 2024	Jefferies	Buy	Buy	Hold
Sep 17, 2024	Jefferies	Hold	Hold	Hold

Row per page

Go to

Teladoc Health's last stock rating was published by Cowen & Co. on Oct 31, 2024. The company gave TDOC a "Hold" rating, the same as its previous rate.

Teladoc Health Financial Forecast

Teladoc Health Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$660.24M	$652.41M	$629.24M	$637.71M	$611.40M	$592.38M	$565.35M	$554.24M	$521.66M	$503.14M	$453.68M	$383.32M	$288.81M
Avg Forecast	$786.92M	$768.01M	$752.18M	$735.73M	$653.09M	$645.39M	$642.25M	$641.35M	$638.22M	$633.91M	$631.62M	$632.60M	$638.84M	$631.18M	$649.16M	$637.31M	$670.81M	$663.54M	$649.18M	$619.30M	$633.40M	$608.89M	$586.74M	$568.68M	$547.17M	$516.63M	$500.60M	$451.91M	$378.93M	$282.18M
High Forecast	$823.57M	$803.78M	$787.21M	$769.99M	$683.51M	$675.45M	$672.16M	$671.22M	$667.95M	$663.44M	$661.04M	$656.35M	$677.01M	$631.48M	$649.33M	$637.31M	$675.14M	$674.54M	$679.42M	$648.14M	$662.90M	$608.89M	$586.74M	$568.68M	$547.17M	$516.63M	$500.60M	$451.91M	$378.93M	$282.18M
Low Forecast	$756.91M	$738.72M	$723.49M	$707.67M	$628.19M	$620.78M	$617.76M	$616.88M	$613.88M	$609.74M	$607.53M	$599.89M	$615.71M	$630.87M	$649.00M	$637.31M	$667.50M	$656.16M	$624.42M	$595.68M	$609.25M	$608.89M	$586.74M	$568.68M	$547.17M	$516.63M	$500.60M	$451.91M	$378.93M	$282.18M
# Analysts	6	6	6	6	9	9	9	9	5	5	5	12	16	8	5	10	11	22	11	11	16	10	10	18	11	13	21	11	15	3
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00%	1.00%	1.02%	1.01%	1.00%	1.01%	0.99%	1.01%	1.01%	1.01%	1.00%	1.01%	1.02%

Teladoc Health's average Quarter revenue forecast for Dec 23 based on 11 analysts is $670.81M, with a low forecast of $667.50M, and a high forecast of $675.14M. TDOC's average Quarter revenue forecast represents a 1.60% increase compared to the company's last Quarter revenue of $660.24M (Sep 23).

Teladoc Health EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	6	6	6	9	9	9	9	5	5	5	12	16	8	5	10	11	22	11	11	16	10	10	18	11	13	21	11	15	3
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$40.39M	$31.15M	$24.51M	$3.83B	$-6.27M	$-1.97M	$-1.27M	$19.75M	$-1.54M	$-12.22M	$-20.27M	$-360.90M	$18.60M
Avg Forecast	$-229.44M	$-223.93M	$-219.31M	$-214.52M	$-190.42M	$-188.18M	$-187.26M	$-187.00M	$-186.09M	$-184.83M	$-184.16M	$-184.45M	$-186.27M	$-184.03M	$-189.28M	$-375.52B	$-195.59M	$-193.47M	$-189.28M	$-401.62B	$28.17M	$85.70M	$82.58M	$-429.54B	$77.01M	$72.71M	$70.46M	$-35.76M	$53.33M	$39.71M
High Forecast	$-220.69M	$-215.39M	$-210.95M	$-206.34M	$-183.16M	$-181.00M	$-180.12M	$-179.87M	$-178.99M	$-177.78M	$-177.14M	$-174.91M	$-179.52M	$-183.94M	$-189.23M	$-300.41B	$-194.62M	$-191.32M	$-182.06M	$-321.30B	$33.80M	$85.70M	$82.58M	$-343.63B	$77.01M	$72.71M	$70.46M	$-28.61M	$53.33M	$39.71M
Low Forecast	$-240.13M	$-234.36M	$-229.53M	$-224.51M	$-199.29M	$-196.94M	$-195.98M	$-195.71M	$-194.75M	$-193.44M	$-192.74M	$-191.37M	$-197.40M	$-184.12M	$-189.32M	$-450.62B	$-196.85M	$-196.68M	$-198.10M	$-481.94B	$22.53M	$85.70M	$82.58M	$-515.45B	$77.01M	$72.71M	$70.46M	$-42.91M	$53.33M	$39.71M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.21%	-0.16%	-0.00%	135.96%	-0.07%	-0.02%	0.00%	0.26%	-0.02%	-0.17%	0.57%	-6.77%	0.47%

11 analysts predict TDOC's average Quarter EBITDA for Dec 23 to be $-195.59M, with a high of $-194.62M and a low of $-196.85M. This is -584.24% lower than Teladoc Health's previous annual EBITDA (Sep 23) of $40.39M.

Teladoc Health Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	6	6	6	9	9	9	9	5	5	5	12	16	8	5	10	11	22	11	11	16	10	10	18	11	13	21	11	15	3
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-57.07M	$-65.18M	$-69.23M	$-3.81B	$-73.48M	$-3.10B	$-6.67B	$-10.98M	$-84.34M	$-133.82M	$-199.65M	$-393.97M	$-35.88M
Avg Forecast	$30.87M	$-17.15M	$-34.30M	$-46.30M	$-34.82M	$-42.87M	$-45.66M	$-59.96M	$-25.89M	$-37.06M	$-39.99M	$-53.88M	$-39.33M	$-47.50M	$-59.10M	$-379.42B	$-37.61M	$-62.51M	$-69.71M	$-405.80B	$-20.39M	$-96.25M	$-104.02M	$-434.01B	$-96.73M	$-114.37M	$-89.96M	$-187.60M	$-44.23M	$-54.76M
High Forecast	$32.74M	$-16.30M	$-32.60M	$-44.01M	$-33.10M	$-40.75M	$-43.40M	$-56.98M	$-24.60M	$-35.22M	$-38.00M	$-32.33M	$-6.21M	$-45.14M	$-56.17M	$-303.54B	$27.35M	$-45.62M	$-66.25M	$-324.64B	$-16.31M	$-96.25M	$-104.02M	$-347.21B	$-96.73M	$-114.37M	$-89.96M	$-150.08M	$-44.23M	$-54.76M
Low Forecast	$29.34M	$-18.19M	$-36.38M	$-49.11M	$-36.93M	$-45.47M	$-48.43M	$-63.59M	$-27.45M	$-39.30M	$-42.41M	$-69.28M	$-53.82M	$-50.38M	$-62.67M	$-455.31B	$-49.57M	$-77.72M	$-73.93M	$-486.96B	$-24.47M	$-96.25M	$-104.02M	$-520.81B	$-96.73M	$-114.37M	$-89.96M	$-225.12M	$-44.23M	$-54.76M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.91%	0.94%	0.00%	186.85%	0.76%	29.82%	0.02%	0.11%	0.74%	1.49%	1.06%	8.91%	0.66%

Teladoc Health's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. TDOC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Teladoc Health SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	6	6	6	9	9	9	9	5	5	5	12	16	8	5	10	11	22	11	11	16	10	10	18	11	13	21	11	15	3
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$301.87M	$358.13M	$345.43M	$322.57M	$346.10M	$333.37M	$296.85M	$290.92M	$276.70M	$278.29M	$259.40M	$531.68M	$135.53M
Avg Forecast	$477.35M	$465.88M	$456.28M	$446.30M	$396.17M	$391.50M	$389.59M	$389.04M	$387.15M	$384.54M	$383.15M	$383.74M	$387.52M	$382.88M	$393.79M	$386.60M	$406.92M	$402.50M	$393.80M	$375.67M	$540.02M	$369.36M	$355.92M	$344.96M	$331.91M	$313.39M	$303.67M	$243.75M	$229.86M	$171.17M
High Forecast	$499.58M	$487.58M	$477.53M	$467.08M	$414.62M	$409.73M	$407.74M	$407.16M	$405.18M	$402.45M	$400.99M	$398.15M	$410.68M	$383.06M	$393.88M	$386.60M	$409.54M	$409.18M	$412.14M	$393.17M	$648.03M	$369.36M	$355.92M	$344.96M	$331.91M	$313.39M	$303.67M	$292.50M	$229.86M	$171.17M
Low Forecast	$459.14M	$448.11M	$438.87M	$429.27M	$381.06M	$376.57M	$374.73M	$374.21M	$372.38M	$369.87M	$368.53M	$363.90M	$373.50M	$382.69M	$393.69M	$386.60M	$404.91M	$398.03M	$378.78M	$361.34M	$432.02M	$369.36M	$355.92M	$344.96M	$331.91M	$313.39M	$303.67M	$195.00M	$229.86M	$171.17M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.75%	0.91%	0.92%	0.60%	0.94%	0.94%	0.86%	0.88%	0.88%	0.92%	1.06%	2.31%	0.79%

Teladoc Health's average Quarter SG&A projection for Dec 23 is $406.92M, based on 11 Wall Street analysts, with a range of $404.91M to $409.54M. The forecast indicates a 34.80% rise compared to TDOC last annual SG&A of $301.87M (Sep 23).

Teladoc Health EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	6	6	6	9	9	9	9	5	5	5	12	16	8	5	10	11	22	11	11	16	10	10	18	11	13	21	11	15	3
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.35	$-0.40	$-0.42	$-23.49	$-0.45	$-19.22	$-41.58	$-0.07	$-0.53	$-0.86	$-1.31	$-3.07	$-0.43
Avg Forecast	$0.18	$-0.10	$-0.20	$-0.27	$-0.20	$-0.25	$-0.27	$-0.35	$-0.15	$-0.22	$-0.23	$-0.31	$-0.23	$-0.28	$-0.34	$-0.46	$-0.22	$-0.36	$-0.41	$-0.48	$-0.25	$-0.57	$-0.61	$-0.60	$-0.57	$-0.67	$-0.53	$-0.54	$-0.26	$-0.32
High Forecast	$0.19	$-0.10	$-0.19	$-0.26	$-0.19	$-0.24	$-0.25	$-0.33	$-0.14	$-0.21	$-0.22	$-0.19	$-0.04	$-0.26	$-0.33	$-0.44	$0.16	$-0.27	$-0.39	$-0.46	$-0.23	$-0.57	$-0.61	$-0.60	$-0.57	$-0.67	$-0.53	$-0.54	$-0.26	$-0.32
Low Forecast	$0.17	$-0.11	$-0.21	$-0.29	$-0.22	$-0.27	$-0.28	$-0.37	$-0.16	$-0.23	$-0.25	$-0.40	$-0.31	$-0.29	$-0.37	$-0.49	$-0.29	$-0.45	$-0.43	$-0.51	$-0.26	$-0.57	$-0.61	$-0.60	$-0.57	$-0.67	$-0.53	$-0.54	$-0.26	$-0.32
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.96%	0.98%	0.87%	95.51%	0.80%	31.46%	69.43%	0.12%	0.79%	1.63%	2.42%	11.82%	1.34%

According to undefined Wall Street analysts, Teladoc Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to TDOC previous annual EPS of $NaN (undefined).

Teladoc Health Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
TDOC	Teladoc Health	$9.00	$50.87	465.22%	Hold
ACCD	Accolade	$3.56	$14.81	316.01%	Buy
GDRX	GoodRx	$4.31	$14.57	238.05%	Buy
TXG	10x Genomics	$13.32	$30.20	126.73%	Hold
PGNY	Progyny	$13.98	$25.29	80.90%	Hold
SDGR	Schrödinger	$19.17	$28.50	48.67%	Buy
GEHC	GE HealthCare	$84.90	$93.90	10.60%	Buy
VEEV	Veeva Systems	$210.63	$229.71	9.06%	Buy
DOCS	Doximity	$49.90	$49.10	-1.60%	Buy
TALK	Talkspace	$3.16	$2.50	-20.89%	Hold

TDOC Forecast FAQ

Is Teladoc Health a good buy?

No, according to 21 Wall Street analysts, Teladoc Health (TDOC) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 47.62% of TDOC's total ratings.

What is TDOC's price target?

Teladoc Health (TDOC) average price target is $50.87 with a range of $9 to $150, implying a 465.22% from its last price of $9. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Teladoc Health stock go up soon?

According to Wall Street analysts' prediction for TDOC stock, the company can go up by 465.22% (from the last price of $9 to the average price target of $50.87), up by 1566.67% based on the highest stock price target, and down by 0% based on the lowest stock price target.

Can Teladoc Health stock reach $14?

TDOC's average twelve months analyst stock price target of $50.87 supports the claim that Teladoc Health can reach $14 in the near future.

What is Teladoc Health's current price target trend?

2 Wall Street analysts forecast a $10 price target for Teladoc Health (TDOC) this month, up 11.11% from its last price of $9. Compared to the last 3 and 12 months, the average price target increased by 11.11% and increased by 46.00%, respectively.

What are Teladoc Health's analysts' financial forecasts?

Teladoc Health's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.58B (high $2.7B, low $2.48B), average EBITDA is $-753M (high $-724M, low $-788M), average net income is $-183M (high $-174M, low $-194M), average SG&A $1.57B (high $1.64B, low $1.51B), and average EPS is $-1.069 (high $-1.016, low $-1.134). TDOC's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $3.04B (high $3.18B, low $2.93B), average EBITDA is $-887M (high $-853M, low $-929M), average net income is $-66.884M (high $-60.166M, low $-74.332M), average SG&A $1.85B (high $1.93B, low $1.78B), and average EPS is $-0.39 (high $-0.351, low $-0.433).

Did the TDOC's actual financial results beat the analysts' financial forecasts?

Based on Teladoc Health's last annual report (Dec 2022), the company's revenue was $2.41B, beating the average analysts forecast of $2.4B by 0.38%. Apple's EBITDA was $13.47B, missing the average prediction of $-429B by -103.14%. The company's net income was $-13.66B, missing the average estimation of $-434B by -96.85%. Apple's SG&A was $1.3B, missing the average forecast of $1.61B by -19.23%. Lastly, the company's EPS was $-84.6, beating the average prediction of $-2.021 by 4085.59%. In terms of the last quarterly report (Sep 2023), Teladoc Health's revenue was $660.24M, missing the average analysts' forecast of $663.54M by -0.50%. The company's EBITDA was $40.39M, missing the average prediction of $-193M by -120.88%. Teladoc Health's net income was $-57.073M, missing the average estimation of $-62.512M by -8.70%. The company's SG&A was $301.87M, missing the average forecast of $402.5M by -25.00%. Lastly, the company's EPS was $-0.35, missing the average prediction of $-0.365 by -3.98%